Cargando…

Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel

The entire time course of leukopenia after anticancer treatment is clinically more relevant than a singly measured nadir count. In order to identify factors associated with neutropenic fever, a mechanistic pharmacodynamic model with two compartments corresponding to leukocytes in bone marrow and per...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Hironobu, Sasaki, Yasutsuna, Watanabe, Torn, Ogawa, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926694/
https://www.ncbi.nlm.nih.gov/pubmed/11223553
http://dx.doi.org/10.1111/j.1349-7006.2001.tb01086.x
_version_ 1783318956232146944
author Minami, Hironobu
Sasaki, Yasutsuna
Watanabe, Torn
Ogawa, Makoto
author_facet Minami, Hironobu
Sasaki, Yasutsuna
Watanabe, Torn
Ogawa, Makoto
author_sort Minami, Hironobu
collection PubMed
description The entire time course of leukopenia after anticancer treatment is clinically more relevant than a singly measured nadir count. In order to identify factors associated with neutropenic fever, a mechanistic pharmacodynamic model with two compartments corresponding to leukocytes in bone marrow and peripheral blood was applied to describe the time course of leukopenia. Seventeen patients with breast cancer were treated with 210 mg/m(2) of paclitaxel infused over 3 h as a single agent in a phase II study. Adequate fitting of the time course of leukopenia was achieved in all patients, and time‐dependent parameters, including the tune period during which leukocyte counts remained below 2000/μl and the area between the curve for time versus leukocyte counts and the line of a leukocyte count of 2000/μl (A <2000), were calculated in each patient. Leukopenia was not significantly correlated with pharmacokinetic parameters, including time above a threshold concentration or the area under the tune‐concentration curve. A negative correlation between age and the sensitivity parameter of the pharmacodynamic model was observed (r(2)=0.21, P=0.07). Patients who experienced neutropenic fever had a larger A<2000 than patients who did not experience fever (4512 vs. 6 days/μl, P=0.05), but fever was not significantly related to any pharmacokinetic parameter or the leukocyte nadir count. Febrile episodes were better associated with the time course of leukopenia than the singly measured nadir count, and the pharmacodynamic model presents a novel platform to analyze the entire tune course of leukopenia.
format Online
Article
Text
id pubmed-5926694
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59266942018-05-11 Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel Minami, Hironobu Sasaki, Yasutsuna Watanabe, Torn Ogawa, Makoto Jpn J Cancer Res Article The entire time course of leukopenia after anticancer treatment is clinically more relevant than a singly measured nadir count. In order to identify factors associated with neutropenic fever, a mechanistic pharmacodynamic model with two compartments corresponding to leukocytes in bone marrow and peripheral blood was applied to describe the time course of leukopenia. Seventeen patients with breast cancer were treated with 210 mg/m(2) of paclitaxel infused over 3 h as a single agent in a phase II study. Adequate fitting of the time course of leukopenia was achieved in all patients, and time‐dependent parameters, including the tune period during which leukocyte counts remained below 2000/μl and the area between the curve for time versus leukocyte counts and the line of a leukocyte count of 2000/μl (A <2000), were calculated in each patient. Leukopenia was not significantly correlated with pharmacokinetic parameters, including time above a threshold concentration or the area under the tune‐concentration curve. A negative correlation between age and the sensitivity parameter of the pharmacodynamic model was observed (r(2)=0.21, P=0.07). Patients who experienced neutropenic fever had a larger A<2000 than patients who did not experience fever (4512 vs. 6 days/μl, P=0.05), but fever was not significantly related to any pharmacokinetic parameter or the leukocyte nadir count. Febrile episodes were better associated with the time course of leukopenia than the singly measured nadir count, and the pharmacodynamic model presents a novel platform to analyze the entire tune course of leukopenia. Blackwell Publishing Ltd 2001-02 /pmc/articles/PMC5926694/ /pubmed/11223553 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01086.x Text en
spellingShingle Article
Minami, Hironobu
Sasaki, Yasutsuna
Watanabe, Torn
Ogawa, Makoto
Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
title Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
title_full Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
title_fullStr Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
title_full_unstemmed Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
title_short Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
title_sort pharmacodynamic modeling of the entire time course of leukopenia after a 3‐hour infusion of paclitaxel
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926694/
https://www.ncbi.nlm.nih.gov/pubmed/11223553
http://dx.doi.org/10.1111/j.1349-7006.2001.tb01086.x
work_keys_str_mv AT minamihironobu pharmacodynamicmodelingoftheentiretimecourseofleukopeniaaftera3hourinfusionofpaclitaxel
AT sasakiyasutsuna pharmacodynamicmodelingoftheentiretimecourseofleukopeniaaftera3hourinfusionofpaclitaxel
AT watanabetorn pharmacodynamicmodelingoftheentiretimecourseofleukopeniaaftera3hourinfusionofpaclitaxel
AT ogawamakoto pharmacodynamicmodelingoftheentiretimecourseofleukopeniaaftera3hourinfusionofpaclitaxel